QRS duration measured in surface ECG was also found to be decreased after drug administration 120.44±23.82 ms versus 116.47±24.56 ms, p = 0.006.
La duración del QRS, medida a partir del ECG de superficie, también disminuyó después de la administración 120,44±23,82 116,47±24,56, p = 0,006.
A duração do QRS, medida a partir do ECG de superfície, também diminuiu após a administração 120,44±23,82 ms versus 116,47±24,56 ms, p = 0,006.